Glenmark Pharmaceuticals
GLENMARK.NS
#2771
Rank
A$7.47 B
Marketcap
$26.48
Share price
-0.57%
Change (1 day)
86.18%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total liabilities

Total liabilities on the balance sheet as of March 2024 : A$1.19 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total liabilities are A$1.19 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Glenmark Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31A$1.72 B28.64%
2022-03-31A$1.34 B-12.06%
2021-03-31A$1.52 B-17.49%
2020-03-31A$1.85 B18.5%
2019-03-31A$1.56 B5.2%
2018-03-31A$1.48 B1.32%
2017-03-31A$1.46 B13.55%
2016-03-31A$1.29 B-7.56%
2015-03-31A$1.39 B37.32%
2014-03-31A$1.01 B31.21%
2013-03-31A$0.77 B18.38%
2012-03-31A$0.65 B-0.62%
2011-03-31A$0.65 B7.46%
2010-03-31A$0.61 B-18.88%
2009-03-31A$0.75 B93.23%
2008-03-31A$0.39 B8.53%
2007-03-31A$0.36 B18.25%
2006-03-31A$0.30 B74.63%
2005-03-31A$0.17 B157.99%
2004-03-31A$67.66 M